Last update 11 Oct 2025

BMT-052

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BMT 052
Target
NS5B polymerase
Action
inhibitors
Mechanism
NS5B polymerase inhibitors(Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors)
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication-
Inactive Indication
Hepatitis C
Originator Organization
Bristol-Myers Squibb FCT bêta, Inc.
Active Organization-
Inactive Organization
Bristol-Myers Squibb FCT bêta, Inc.
License Organization-
Drug Highest PhasePendingDiscovery
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC30H26F4N6O5
InChIKeyRIVZWIZZJKKNQV-FZGWONOOSA-N
CAS Registry1628720-84-2

Related

100 Clinical Results associated with BMT-052
Login to view more data
100 Translational Medicine associated with BMT-052
Login to view more data
100 Patents (Medical) associated with BMT-052
Login to view more data
1
Literatures (Medical) associated with BMT-052
13 Jul 2017ACS medicinal chemistry lettersQ3 · MEDICINE
Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase Inhibitor
Q3 · MEDICINE
100 Deals associated with BMT-052
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis CDiscovery
United States
Bristol-Myers Squibb FCT bêta, Inc.
13 Jul 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free